18 mar 2019
CPhI Japan 2019

About us

Hovione has 60 years of experience as a CDMO and is a fully integrated supplier offering services for drug substance, drug product intermediate and drug product. With four FDA inspected sites in the USA, China, Ireland and Portugal and development laboratories in Portugal and USA, the company provides branded pharmaceutical customers services for the development and compliant manufacture of innovative drugs including highly potent compounds. 

Hovione offers a full range of development services and manufacturing capacity in particle engineering (Spray Drying, Spray Congealing, Hot Melt Extrusion, Jet Milling, Nanoparticles and Wet Polishing) to provide optimal solutions for your drug product with the right scale and flexibility. For generic pharmaceutical customers the company offers niche API products. Hovione also provides proprietary product development and licensing opportunities for drug products. In the inhalation area, Hovione is the only independent company offering a complete range of services.  Please visit www.hovione.com

Specs about this supplier

Sales markets Western Europe; Middle East; Asia; Australia; North America
Affiliated categories: Aerosols |API Contract Manufacturing |Bioavailability enhancement More

Products featured at CPhI Japan 2019

Hovione

Event information

CPhI Japan 2019

18 - 20 March 2019 Tokyo, Japan Visit us at stand 2A-20